Kyphon Newswire (Page 3)

Kyphon Newswire (Page 3)

Comprehensive Real-Time News Feed for Kyphon. (Page 3)

Results 41 - 60 of 250 in Kyphon

  1. How Medtronic Misplaced 1000 Negative Infuse ReportsRead the original story w/Photo

    Apr 11, 2016 | Medical Device/Diagnostic Ind.

    At the time Medtronic supposedly lost the study results, there were only a few hundred Infuse-related problems in FDA's public database, according to Minneapolis' major daily newspaper. Adverse event reports now number in the thousands.

    Comment?

  2. K2M Gaining On Entrenched Rivals In An Overlooked SpaceRead the original story w/Photo

    Apr 9, 2016 | Seeking Alpha

    K2M is looking to disrupt the long-term duopoly between Medtronic and Johnson & Johnson in the almost $1.6 billion complex spine care market. Innovation has driven market share growth so far, as K2M has developed a series of products that are faster and easier to use and less invasive for the patient.

    Comment?

  3. FDA Approves Smallest Pacemaker, Developed By MedtronicRead the original story w/Photo

    Apr 7, 2016 | CBS Local

    TV is part of CBS Television Stations, a division of CBS Corp. and one of the largest network-owned station groups in the country. Click here for WCCO-TV news stories Send us your breaking news tips [...] 830 WCCO Welcome to News Radio 830 WCCO on CBSMinnesota.com! WCCO is part of CBS Radio, a division of CBS Corp. and one of the largest network-owned station groups in the country.

    Comment?

  4. The Wall Street Journal: Medtronic says new inversion rules won't hurt financesRead the original story w/Photo

    Apr 6, 2016 | MarketWatch

    Medtronic Inc. on Wednesday said the Treasury Department's new proposed tax regulations on inversion deals won't have a material financial impact on the medical supply company, which moved its corporate address abroad in a deal last year. closed a $43 billion acquisition of Ireland's Covidien PLC, combining two of the world's largest medical-supply companies.

    Comment?

  5. Medtronic Still Unfazed by New Inversion RulesRead the original story

    Apr 5, 2016 | BioSpace

    April 6, 2016 - Medtronic plc has conducted a preliminary review of the United States Department of Treasury Temporary and Proposed Regulations issued on April 4, 2016, which are designed to address certain concerns around transactions referred to by Treasury as "tax inversions" and "earnings stripping." Medtronic has concluded that the Temporary and Proposed Regulations do not have a material financial impact on any transaction undertaken by the company.

    Comment?

  6. Medtronic Starts CoreValve Evolut R Trial in Low-Risk PatientsRead the original story

    Mar 31, 2016 | BioSpace

    First Patients Enrolled In Medtronic Trial In Low-Risk Aortic Stenosis Patients DUBLIN - March 31, 2016 - Medtronic plc today announced that the first patients were enrolled in the expanded indication trial for the CoreValveA EvolutA R System, the first and only next-generation recapturable, self-expanding transcatheter aortic valve replacement system commercially available in the United States. The first patients were enrolled at PinnacleHealth CardioVascular Institute in Harrisburg, PA.

    Comment?

  7. Medtronic Announces Cash Tender Offer For Up To $2.75 Billion...Read the original story

    Mar 31, 2016 | BioSpace

    March 31, 2016 - Medtronic plc today announced the commencement of a cash tender offer by its wholly-owned subsidiaries, Medtronic, Inc. and Covidien International Finance S.A. , for up to $2.75 billion combined aggregate purchase price of CIFSA's 6.550% Senior Notes due 2037 and 2.950% Senior Notes due 2023 and Medtronic, Inc.'s 4.000% Senior Notes due 2043, 2.750% Senior Notes due 2023, 4.450% Senior Notes due 2020, 4.375% Senior Notes due 2035 and 2.500% Senior Notes due 2020 . The purpose of the Tender Offer is to reduce the level of the Company's indebtedness, consistent with the capital allocation plans announced by the Company on January 11, 2016.

    Comment?

  8. Medtronic Snags Expanded Indication for Pillcam Colon 2Read the original story

    Mar 30, 2016 | BioSpace

    Medtronic Receives Expanded Indication From FDA for Pillcam Colon 2 Capsule - Potentially Reaching More Patients at Risk for Colon Cancer DUBLIN - March 31, 2016 - Medtronic plc today announced that the U.S. Food and Drug Administration cleared PillCam COLON 2 capsule is the only non-invasive diagnostic test that directly visualizes the colon for the evaluation of polyps in patients who are at major risks for colonoscopy or moderate sedation. The PillCam capsule- a vitamin-sized capsule endoscope that is taken orally - does not require sedation, anesthesia or radiation, which makes it a more convenient procedure than other invasive colon exams.

    Comment?

  9. Medtronic probed for breach of contract:...Read the original story w/Photo

    Mar 27, 2016 | Korea Herald

    Medical equipment-maker Medtronic is under investigation by Korea's Fair Trade Commission for breaching contracts with local distributors, according to sources Sunday. Medtronic Korea, the local branch of the global medical equipment firm, has abruptly canceled contracts, which were still valid with local distributors who have maintained partnerships for more than a decade with the medical device giant.

    Comment?

  10. Medtronic to move two manufacturing lines from its Louisville facilityRead the original story

    Mar 21, 2016 | LongmontFYI

    Medtronic Corp. , one Boulder County's largest employers, is relocating two of its manufacturing lines from its Louisville facility.

    Comment?

  11. Medtronic to Shutter Ex-Covidien HQ in MassachusettsRead the original story

    Mar 8, 2016 | BioSpace

    Medtronic is reportedly planning to shutter the former headquarters of Covidien more than a year after its $50 billion acquisition of the Mansfield, Mass.-based company. The closure, slated for later this spring, was decided upon last fall, Medtronic spokesman Fernando Vivanco told the Attleboro Sun Chronicle.

    Comment?

  12. With Wright Medical, It Seems Like Something Is Always A Little WrongRead the original story w/Photo

    Mar 8, 2016 | Seeking Alpha

    Every market day, we select up to 20 of our authors' top long and short ideas, exclusively for PRO subscribers. Wright Medical is seeing good sales momentum in its core growth businesses along with strong initial interest in its new Augment biological.

    Comment?

  13. Medtronic EVP & President To Speak At Cowen and Company Healthcare ConferenceRead the original story

    Mar 3, 2016 | BioSpace

    Mar 4, 2016 - Medtronic plc , a global leader in medical technology, services, and solutions, today announced it will participate in the 36th Annual Cowen & Company Healthcare Conference on Tuesday, March 8, 2016, in Boston, Massachusetts. Mike Coyle, executive vice president and president of Medtronic's Cardiac and Vascular Group, will make a formal presentation on the company beginning at 11:20 a.m. EST .

    Comment?

  14. Medtronic Spine is Still Hobbled OverRead the original story w/Photo

    Mar 2, 2016 | Medical Device/Diagnostic Ind.

    ... luster. Additionally, under its previous CEO Bill Hawkins, Medtronic made an expensive near $4 billion acquisition of Kyphon that made balloon kyphoplasty products to treat spinal fractures. That acquisition never quite panned out and in 2013, ...

    Comment?

  15. Once Upon a Crime mystery bookstore has new ownersRead the original story w/Photo

    Mar 1, 2016 | City Pages

    Seven months ago, we reported the Once Upon a Crime was for sale . After 13 years, Pat Frovarp and Gary Shulze are ready to hand the reigns over to new owners.

    Comment?

  16. AxioMed's AAOS Event Will Feature Speaker Dr. Mark Reiley - A...Read the original story

    Feb 26, 2016 | PRWeb

    ... who did his first total segment motion preservation procedure in Berlin over 10 years ago. Dr. Reiley co-founded Kyphon based on his invention of the Kyphon balloon device to treat fractured vertebrae. Reiley sold Kyphon to Medtronic in 2007. He ...

    Comment?

  17. Press release distribution, EDGAR filing, XBRL, regulatory filingsRead the original story

    Feb 24, 2016 | Business Wire

    Fourth Quarter and Year... )--Breitburn Energy Partners LP announced today distributions for its 8.25% Series A Cumulative Redeemable Perpetual Preferred Units and 8% ... )--Research and Markets has announced the addition of the "Global Market for Amino Acids as Compound Feed... )--Emera Inc. and Emera Inc. today announced that ECI's shareholders have approved an a... )--Research and Markets has announced the addition of the "North America Food Additives Market" report to the... )--Fitch Ratings has taken the following rating actions on Nelnet Student Loan Trust 2008-4: --Class A-3 affirmed at 'AAAsf'; Outlook Stable;--Class A-4 'AAAsf' maintained o... )--Fitch Ratings assigns an 'AAA' rating to the following Normal, Illinois bonds: --$8.54 million general obligation refunding bonds, series 2016A; --$8.83 m... )--Panasonic Broadcasts Total Eclipse Live Using Solar Energy from its Power ... (more)

    Comment?

  18. Bakken Library and MuseumRead the original story w/Photo

    Feb 24, 2016 | City Pages

    The stately Bakken Museum is located in an 85-year-old Tudor mansion on the west shore of Lake Calhoun. Named for Minneapolis native Earl Bakken -- the pioneering co-founder of Medtronic, whose use of electricity for therapeutic and medical purposes drove him to create the first wearable, battery-powered pacemaker -- the Bakken is dedicated to educating the young and old alike about the innumerable mysteries to be found in the world of electricity.

    Comment?

  19. Sanders is right to decry firms' legal tax dodgeRead the original story w/Photo

    Feb 19, 2016 | Dallas Morning News

    I'm a dyed-in-the-wool free market guy, so I typically don't find myself on the same side of an issue as the wild-haired, lovable socialist and presidential candidate Bernie Sanders. But shockingly, that is where I currently reside, at least on one issue.

    Comment?

  20. Medtronic To Announce Financial Results For Its Third Quarter Of Fiscal Year 2016Read the original story

    Feb 18, 2016 | BioSpace

    February 19, 2016 - Medtronic plc announced today it will report financial results for the third quarter of its fiscal year 2016 on Tuesday, March 1, 2016. A news release will be issued at approximately 5:45 a.m. Central Standard Time and will be available at http://newsroom.medtronic.com.

    Comment?